© Copyright Medtech Limited Page 1 of 28
EMPOWERING HEALTH
Release Notes
Medtech32
Version 22.9 – Build 5424
(June 2017)
These release notes contain important information for Medtech32 users. Please ensure that
they are circulated among all relevant staff. We suggest that they are filed safely for future
reference.
© Copyright Medtech Limited Page 2 of 28
EMPOWERING HEALTH
Table of Contents
Introduction 4
NEW ENHANCEMENTS 4
Changes to the National Immunisation Schedule July 2017 5
New 2017 Immunisation Schedules 6
SETUP OF 2017 IMMUNISATION SCHEDULES 6
IMMUNISATION SCHEDULES FOR 2017 7
TRANSITIONING PATIENTS FROM THE 2014 IMMUNISATION SCHEDULE 8
Rotavirus Monovalent Vaccination 11
NEW ROTAVIRUS MONOVALENT VACCINE 11
Pneumococcal Vaccination 12
CHANGES TO PNEUMOCOCCAL VACCINATION 12
Varicella Vaccination 13
NEW VARICELLA VACCINES 13
HPV9 Vaccination 15
INCLUDING HPV9 VACCINES WITHIN CHILDHOOD IMMUNISATION SCHEDULE 15
New High Risk Vaccinations 18
SETUP OF HIGH RISK VACCINES 18
NEW HIGH RISK VACCINES 18
Increase in Dosage Interval between 23PPV Vaccines 23
CHANGES TO 23PPV VACCINE-CONTAINING SCHEDULES 23
Changes to Valid Alternatives of Tdap-11y Vaccine 25
ADDITION OF NEW VALID ALTERNATIVE VACCINE FOR TDAP-11Y 25
MESSAGING OF ALL VALID ALTERNATIVES OF TDAP-11Y VACCINE TO NIR 26
General Changes 27
MEDTECH32 IMMUNISATION AUDIT REPORT 27
NIR IMMUNISATION AUDIT REPORT 27
© Copyright Medtech Limited Page 3 of 28
EMPOWERING HEALTH
IMMUNISATION MERGE FIELD 27
OUTBOX DOCUMENT WIZARD 27
PROVIDER INBOX – VACCINE UPDATE MESSAGES 27
LINK TO 2017 IMMUNISATION HANDBOOK FROM IMMUNISATION SCREEN 27
© Copyright Medtech Limited Page 4 of 28
EMPOWERING HEALTH
Introduction
These release notes provide an overview of the enhancements made within Medtech32
Version 22.9 Build 5424 to support the new NIR schedule changes that will come into effect
from 1 July 2017.
New Enhancements
Description of Change Category Impact
The following changes have been made in Medtech32 to support the
Ministry of Health’s requirements for the July 2017 NIR Schedule
changes:
Creation of a new Childhood Immunisation Schedule for 2017
Creation of new Catch-Up Schedules for 2017
Creation of a new Baby of Hepatitis B Mother Schedule for 2017
Pneumococcal 10-valent protein conjugate vaccine (PCV10) has
replaced the pneumococcal 13-valent protein conjugate vaccine
(PCV13) in the Childhood Immunisation Schedule for 2017
Rotavirus monovalent vaccine has replaced the rotavirus
pentavalent vaccine. This new vaccine must be given at 6 weeks
and 3 months only; a third vaccination at 5 months is no longer
required
Varicella vaccine has been added to the Childhood Immunisation
Schedule for 2017, with a single dose to be given at 15 months
A standalone Varicella vaccine has been included to be given at
11 years of age, if the patient has never had a Varicella infection or
has not previously received the Varicella vaccine
HPV9 vaccines have been introduced under the Childhood
Immunisation Schedule for 2017
New High Risk vaccines have been created for the following:
PCV13, Hib, Meningococcal B, Hepatitis B (Paed/Adol), Hepatitis B
(Adult)
The interval between the two 23 PPV vaccine doses has been
increased from 3 years to 5 years
Ensure that all alternative vaccines to Tdap-11 years are being sent
to NIR
Regulatory Major
© Copyright Medtech Limited Page 5 of 28
EMPOWERING HEALTH
Changes to the National Immunisation
Schedule July 2017
The Ministry of Health has confirmed the following changes to the National Immunisation
Schedule, effective from 1 July 2017.
The 13-valent pneumococcal vaccine [Prevenar 13; PCV13] will be replaced by the
10-valent PCV10 vaccine [Synflorix].
Prevenar 13 (PCV13) will remain available for high-risk patients only.
Under the Childhood Immunisation Schedule, the three-dose rotavirus pentavalent
vaccine [RotaTeq] schedule will be replaced by a two-dose rotavirus monovalent
vaccine [Rotarix] schedule, except where a patient has started the rotavirus
pentavalent vaccine schedule. In this scenario, the patient will be able to complete
their original three-dose regimen with Rotarix (monovalent) or, while stocks remain, with
RotaTeq (pentavalent).
Funded access to the Varicella vaccine (Varilrix) will be widened to include one dose
for primary vaccination in children at 15 months, and for previously unvaccinated
children turning 11 years on or after 1 July 2017 who have not had a previous Varicella
(chickenpox) infection.
From 1 July 2017, the Human Papillomavirus 9 valent Vaccine (HPV9) will be scheduled
within the Childhood Immunisation Schedule in MedTech32 and not as a standalone
HPV schedule.
New High Risk vaccines will be messaged to NIR. The new high-risk vaccines are Hib,
PCV13, Meningococcal B, Hepatitis B (Adol/Paed) and Hepatitis B (Adult).
Increase in the dosage interval period between 23PPV Dose 1 and 23PPV Dose 2 from
three years to five years.
Ensuring that there are no messaging restrictions (like Birth Cohort rules) for any valid
alternative to the Tdap-11y vaccine.
© Copyright Medtech Limited Page 6 of 28
EMPOWERING HEALTH
New 2017 Immunisation Schedules
Setup of 2017 Immunisation Schedules
Setup ► Recall/Screening ► Immunisation Schedule
The following new schedules have been added to Medtech32 for the 2017 Immunisation
Schedule changes:
New Schedules Schedule Details
Childhood Immunisation Schedule Childhood Immunisation Schedule 2017
Hepatitis B Schedule Baby of HepB Positive Mother 2017
Catch-Up Schedules
Std CU 12-14 wks 1st dose 2017
Std CU 15 wks-6 mths 1st dose 2017
Std CU 7-11 mths 1st dose 2017
Std CU 12-23 mths 1st dose 2017
Std CU 24-44 mths 1st dose 2017
Std CU 45-59 mths 1st dose 2017
Std CU 5-9yrs 1st dose 2017
Std CU 10-17 yrs 1st Dose 2017
Std CU 18+ yrs 1st Dose 2017
Std CU 11-14 yrs 1st dose (HPV9 only)
2017
Std CU 15-26 yrs 1st dose (HPV9 only)
2017
Please note: the Catch-Up schedules will not have dose of the HPV9 vaccine available as part
of the schedule 11 year vaccination tasks. Instead there are two separate HPV9 Catch-Up
schedules for the age groups of 1114 years and 1526 years; these can be used based on
the patient’s age at the time of vaccination.
Under the Catch-Up Schedule Setup screen, the HPV9 Vaccine Groups have been added by
default in the Group Members tab. This is due to the presence of a corresponding 11Y17 Group.
But as stated above, the 11-year-old HPV9 vaccine tasks will not be available in the Catch-Up
Schedules.
© Copyright Medtech Limited Page 7 of 28
EMPOWERING HEALTH
Immunisation Schedules for 2017
Module ► Immunisations
The new 2017 Immunisation Schedules replace the current 2014 Immunisation Schedules and
will be available for selection under the Schedule Selection tab of the Immunisation module.
All the new schedules include tasks for the new rotavirus monovalent vaccine (at ages 6W &
3M), Varicella vaccine (at age 15M) and HPV9 vaccine (at age 11Y).
The PCV13 vaccine has been replaced with PCV10 (at ages 6W, 3M, 5M & 15M).
© Copyright Medtech Limited Page 8 of 28
EMPOWERING HEALTH
Transitioning patients from the 2014 Immunisation Schedule
Children aged less than 6 weeks (5 weeks and 6 days) on 1 July 2017 will be added to the new
Childhood Immunisation Schedule for 2017.
Children who are due or overdue for their 6W, 3M, 5M or 15M immunisations (under the
Childhood Immunisation Schedule 2014) on or after 1 July 2017 will be transferred to the new
Childhood Immunisation Schedule for 2017. This will enable them to receive the new rotavirus
monovalent, PCV10 and Varicella vaccines.
After moving to the new 2017 Childhood Immunisation schedule, the following changes will be
noted:
If the child has received PCV13 vaccination under the 2014 schedule, then on
transferring to the new 2017 schedule, vaccination with the PCV10 vaccine under the
new schedule will be updated with the ‘Alternative Given’ outcome.
If the child has received the DTaP-IPV-HepB/Hib vaccine under the 2014 schedule, then
on transferring to the new 2017 schedule, the DTaP-IPV-HepB/Hib vaccine in the new
schedule will be updated with the ‘Given’ outcome.
All vaccines received under the 2014 schedule will be displayed under the All
Immunisation tab.
There are special transition rules for the rotavirus vaccines and these are outlined below:
Number of Rotavirus Pentavalent
doses received under 2014 Schedule
Number of Rotavirus Monovalent doses required
in New Schedule
3 Rotavirus pentavalent doses No Rotavirus monovalent doses required
2 Rotavirus pentavalent doses
(i.e. received doses at 6W & 3M, did
not receive third dose at 5M)
a. According to the Ministry of Health, one dose of
the Rotavirus monovalent vaccine must be
given to the patient; the interval between this
dose and the second Rotavirus pentavalent
dose (given under the 2014 schedule) must be
more than 4 weeks.
The Rotavirus mono, Dose 2 vaccine will be
given to the patient under the 5 months
schedule.
b. The Rotavirus mono, Dose 1 under the CI 2017
schedule will be automatically updated with the
status of ‘Alternative Given’ and will be
displayed under the 6 weeks schedule.
c. If the patient’s age is older than 24 weeks and
6 days, and the Rotavirus mono, Dose 2 has not
been given, then this vaccine will be
automatically closed-off with the status of
‘Closed Not Required’ (Rotavirus mono, Dose 1
will have the status of ‘Alternative Given’)
© Copyright Medtech Limited Page 9 of 28
EMPOWERING HEALTH
Number of Rotavirus Pentavalent
doses received under 2014 Schedule
Number of Rotavirus Monovalent doses required
in New Schedule
1 Rotavirus pentavalent dose
(i.e. received 1 dose at 6W, did not
receive the second and third doses
at 3M & 5M)
a. According to the Ministry of Health, two doses of
the Rotavirus monovalent vaccine doses must
be given to the patient. A minimum gap of at
least 4 weeks must be maintained between the
two doses.
b. The patient will receive Rotavirus mono, Dose 1
under the 3 months schedule.
c. Rotavirus mono, Dose 2 will be administered
under the 5 months schedule.
d. If the patient’s age is greater than 24 weeks and
6 days, and the Rotavirus mono, Dose 1 and
Rotavirus mono, Dose 2 have not been given,
then these vaccines will be automatically
closed-off with the status of ‘Closed Not
Required’
The screenshot given below displays the transition of a patient from 2014 to 2017 Childhood
Immunisation Schedule who have immunisations due under the 3M, 5M and 15M groups.
Similarly the screenshot given below displays the transition of a patient from 2014 to 2017
Childhood Immunisation Schedule who have immunisations due under the 5M and 15M
groups.
© Copyright Medtech Limited Page 10 of 28
EMPOWERING HEALTH
Please note: there will be a Transition Utility available in the Medtech32 Version 22.9 Build 5424.
After installing this build, the transition utility will be triggered when the first user at the practice
logs into Medtech32 on or after 1 July 2017.
© Copyright Medtech Limited Page 11 of 28
EMPOWERING HEALTH
Rotavirus Monovalent Vaccination
New Rotavirus Monovalent Vaccine
Setup ► Recall/Screening ► Vaccine
Module ► Immunisations
A new Rotavirus vaccine has been added under the 2017 Immunisation Schedules. This
vaccine will be available under the scheduled 6-week and 3-month vaccination tasks.
Vaccine Codes Vaccine Names
ROTAM1 Rotavirus mono, Dose1
ROTAM2 Rotavirus mono, Dose2
The child will not be able to receive their first dose of the rotavirus monovalent vaccine if they
are older than 14 weeks and 6 days.
If the child is older than 14 weeks and 6 days and they have not received their first dose of the
vaccine, then the incomplete Rotavirus vaccination tasks (both 1st and 2nd doses) will be
updated automatically with the Outcome status of ‘Closed Not Required’.
Similarly, both the Rotavirus Monovalent vaccination tasks must be completed by the age of
24 weeks and 6 days.
If the child is older than 24 weeks and 6 days and they have not completed the Rotavirus
vaccination tasks (second dose not yet given), then the incomplete Rotavirus vaccination task
will be automatically updated with the Outcome status of ‘Closed Not Required’.
© Copyright Medtech Limited Page 12 of 28
EMPOWERING HEALTH
Pneumococcal Vaccination
Changes to Pneumococcal Vaccination
Setup ► Recall/Screening ► Vaccine
Module ► Immunisations
Under the 2014 schedules, the PCV13 vaccine was available for administration to children at
age 6W, 3M, 5M and 15M. This vaccine has been replaced with the PCV10 vaccine in all
immunisation schedules for 2017.
Vaccine Codes Vaccine Names
PC10-1 Pneum, conj 10, 6w
PC10-2 Pneum, conj 10, 3m
PC10-3 Pneum, conj 10, 5m
PC10-4 Pneum, conj 10, 15m
The change from PCV13 to PCV10 vaccination is only for the 2017 Childhood Immunisation
Schedule, Catch-Up schedules and Baby of Hep B Mother schedules.
Please note: the PCV13 vaccine will not be replaced with PCV10 vaccine under the 2014
Pneumococcal Schedules.
The PCV13 vaccine will still be available as a valid alternative to the new PCV10 vaccine.
© Copyright Medtech Limited Page 13 of 28
EMPOWERING HEALTH
Varicella Vaccination
New Varicella Vaccines
Setup ► Recall/Screening ► Vaccine
Module ► Immunisations
A new Varicella vaccine has been added under the 2017 Childhood Immunisation Schedule.
From 1 July 2017 all individuals born on or after 1 April 2016 are eligible to receive the Varicella
vaccine, which will be available under the 15-month vaccination tasks.
Vaccine Codes Vaccine Names
VAR15M Varicella 15m
VAR11Y Varicella 11y
Children who are due or overdue for their 15-month vaccination tasks under the 2014 schedule
will be transitioned into the 2017 Childhood Immunisation Schedule so that they will receive
the Varicella 15-month vaccination task.
The Varicella vaccine (Varicella 11y) can be administered to 11 years old outside of the
Childhood Immunisation Schedule, via the Single Syringe icon under the Immunisation
Schedule tab and the All Immunisations tab. However, this is restricted to previously
unvaccinated children turning 11 years old on or after 1 July 2017 who have not had a previous
Varicella infection (chickenpox).
© Copyright Medtech Limited Page 14 of 28
EMPOWERING HEALTH
© Copyright Medtech Limited Page 15 of 28
EMPOWERING HEALTH
HPV9 Vaccination
Including HPV9 Vaccines within Childhood Immunisation Schedule
Module ► Immunisations
From 1 July 2017, the HPV9 vaccination tasks (for children aged 1114 years) will be scheduled
within the Childhood Immunisation programme in Medtech32 and not as a standalone HPV9
Vaccine programme.
By default, the schedule will have three doses of the HPV9 vaccine with the first vaccine
scheduled when the child is aged 11 years. The schedule dosage intervals are as follows:
HPV9 – Dose 1 (at age 11 years)
HPV9 – Dose 2 (6 months after Dose 1)
HPV9 – Dose 3 (4 months after Dose 2)
As per the Ministry of Health guidelines, based on a child’s age and the intervals between the
doses, the total number of HPV9 doses to be given will vary.
The details for these dosage variations are given below:
1. If the child receives the first two doses of the HPV9 vaccine, at least 5 months apart,
then they do not have to receive a third dose of the HPV9 vaccine. In this scenario, the
HPV9 Dose 3 can be manually closed off with the Outcome of Closed Not Required.
2. If the child receives the first two doses of the HPV9 vaccine, less than 5 months apart,
then they must receive a third dose of the HPV9 vaccine to be fully immunised.
3. If the child does not receive their second HPV9 dose by age 14 years and 364 days,
then they must receive the remaining two doses of the HPV9 vaccine to be fully
immunised.
© Copyright Medtech Limited Page 16 of 28
EMPOWERING HEALTH
The existing standalone vaccination schedule of ‘HPV9 Vaccine Schedule 9-14 yrs’ will be
available to cater to the 914 year age group. This schedule can be used under the following
circumstance:
Children who are on an older immunisation schedule (e.g. 2014, 2011, 2008, etc.) that
does not include the HPV9 vaccine doses.
Similarly the existing standalone vaccination schedule of ‘HPV9 Vaccine Schedule 15-26 yrs’
will be available to cater to the 1526 year age group. This schedule can be used under the
following circumstances:
Children who are on an older immunisation schedule (e.g. 2014, 2011, 2008, etc.) that
does not include the HPV9 vaccine doses.
If the child has not started the HPV9 Dose 1 vaccine, available under the 2017
Immunisation Schedule by age 15 years, then the practice must use this standalone
schedule to complete the required HPV9 doses.
© Copyright Medtech Limited Page 17 of 28
EMPOWERING HEALTH
© Copyright Medtech Limited Page 18 of 28
EMPOWERING HEALTH
New High Risk Vaccinations
Setup of High Risk Vaccines
Setup ► Recall/Screening ► Vaccine
Various new High Risk funded vaccines have been introduced in Medtech32.
Vaccine Codes Vaccine Names Purpose
PCV13H PCV13 High Risk
To be given to high-risk children (not covered
by current pneumococcal programme) and
high-risk adults
HIBHR Hib High Risk To be given to high-risk children and adults
MENBHR MenB High Risk
To be given to high-risk children and adults
during an outbreak of Meningococcal B
infection in NZ
HEPBHR HepB Paed High Risk To be given to high-risk children and
adolescents
HEPBAH HepB Adult High Risk To be given to high-risk adults
New High Risk Vaccines
Module ► Immunisations
The new High Risk vaccines will cater to high-risk children and adults.
These High Risk vaccines will be available for selection via the Single Syringe icon under the
Immunisation Schedule tab and the All Immunisations tab.
These vaccines will be messaged to NIR irrespective of the patient’s age.
© Copyright Medtech Limited Page 19 of 28
EMPOWERING HEALTH
© Copyright Medtech Limited Page 20 of 28
EMPOWERING HEALTH
© Copyright Medtech Limited Page 21 of 28
EMPOWERING HEALTH
© Copyright Medtech Limited Page 22 of 28
EMPOWERING HEALTH
© Copyright Medtech Limited Page 23 of 28
EMPOWERING HEALTH
Increase in Dosage Interval between 23PPV
Vaccines
Changes to 23PPV Vaccine-containing Schedules
Setup ► Recall/Screening ► Vaccine Group
Module ► Immunisations
Based on a directive from the Ministry of Health, the dosage interval between the two 23 PPV
vaccine doses (Pneum, poly 1st & Pneum, poly 2nd) has been increased from 3 years to 5 years.
This has been implemented by updating the ‘Due at Age’ date or ‘Due from Schedule Start’
date for all vaccine groups containing the second 23PPV dose.
If a patient is already on an immunisation schedule containing the 23PPV vaccine, then the
recall period will be amended from 3 years to 5 years for the second dose of 23PPV (Pneum,
poly 2nd vaccine).
© Copyright Medtech Limited Page 24 of 28
EMPOWERING HEALTH
This change in the dosage intervals between two 23PPV vaccines will affect the following
immunisation schedules:
1. Pneum schedule (6W to 6M) 2014
2. Pneum schedule (7M to 11M) 2014
3. Pneum schedule (12M to 21M) 2014
4. Pneum schedule (22M to 47M) 2014
5. Pneum 1 prev PCV (2 to 5Y) 2014
6. Pneum 2 prev PCV (2 to 5Y) 2014
7. Pneum 3 prev PCV (2 to 5Y) 2014
8. Pneum 4 prev PCV (2 to 5Y) 2014
9. Pneum 1 prev 23PPV (2 to 5Y) 2014
10. Pneum schedule (6W to 6M) 2011
11. Pneum schedule (7M to 11M) 2011
12. Pneum schedule (12M to 21M) 2011
13. Pneum schedule (22M to 47M) 2011
14. Pneum 1 prev PCV (2 to 5Y) 2011
15. Pneum 2 prev PCV (2 to 5Y) 2011
16. Pneum 3 prev PCV (2 to 5Y) 2011
17. Pneum 4 prev PCV (2 to 5Y) 2011
18. Pneum 1 prev 23PPV (2 to 5Y) 2011
19. Pneum schedule (6W to 6M)
20. Pneum schedule (7M to 11M)
21. Pneum schedule (12M to 21M)
22. Pneum schedule (22M to 47M)
23. Pneum 1 prev PCV (2 to 5Y)
24. Pneum 2 prev PCV (2 to 5Y)
25. Pneum 3 prev PCV (2 to 5Y)
26. Pneum 4 prev PCV (2 to 5Y)
27. Pneum 1 prev 23PPv (2 to 5Y)
© Copyright Medtech Limited Page 25 of 28
EMPOWERING HEALTH
Changes to Valid Alternatives of Tdap-11y
Vaccine
Addition of new Valid Alternative Vaccine for Tdap-11y
Module ► Immunisations
The Tdap-11y vaccine given to children at age 11 years was missing the IPV vaccine as an
Alternative Given selection option. The IPV vaccine has now been added.
With the addition of this alternative vaccine, the different Alternative Given selection options
available for Tdap-11y vaccine are as follows:
1. TT11y
2. Td11y
3. d11y
4. dTap-IPV 11y
5. IPV misc/11y
© Copyright Medtech Limited Page 26 of 28
EMPOWERING HEALTH
Messaging of all Valid Alternatives of Tdap-11y Vaccine to NIR
All valid alternative vaccines given for Tdap-11y vaccine will be sent to NIR, irrespective of the
patient’s Date of Birth (the Age Cohort rule will be disabled for this).
Currently, the Age Cohort rule states that immunisation details will be sent to NIR only for those
patients whose Date of Birth (DoB) falls after the NIR Go Live date.
As part of the change, for a patient who receives one of the valid alternative vaccines for
Tdap-11y vaccine, the vaccine details will be sent to NIR even if the patient’s DoB falls before
the NIR Go Live date.
© Copyright Medtech Limited Page 27 of 28
EMPOWERING HEALTH
General Changes
Medtech32 Immunisation Audit Report
Report ► Immunisations ► MT32 Imm Audit
The Medtech32 Immunisation Audit Report has been updated to include the new 2017
Childhood Immunisation Schedule vaccines.
NIR Immunisation Audit Report
Report ► Immunisations ► NIR Imm Audit
The NIR Immunisation Audit Report has been updated to include the new 2017 Childhood
Immunisation Schedule vaccines.
Immunisation Merge Field
Setup ► In/OutBox ► Outbox Document
The Immunisation merge field has been updated to include the new 2017 Immunisation
Schedule vaccines.
Outbox Document Wizard
Module ► Out Box ► New Document (Wizard Button)
The Immunisations section in the More tab of the Out Box Document Wizard has been updated
to include the new vaccine codes for the 2017 Immunisation Schedules.
Provider Inbox – Vaccine Update Messages
Module ► Inbox ► Provider Inbox
The Provider Inbox display for Immunisation Update messages has been updated to ensure
correct formatting and display of 2017 Immunisation Schedule vaccines, when importing these
vaccines for different patients.
Link to 2017 Immunisation Handbook from Immunisation Screen
Module ► Immunisations
A new Help icon has been added under the Immunisation Status screen. Clicking this icon
will open the PDF version of the latest 2017 Immunisation Handbook.
© Copyright Medtech Limited Page 28 of 28
EMPOWERING HEALTH
For further information or any other queries, please contact Medtech Support via:
Medtech32 application [Help ► Contact Support]
Online chat: www.medtechglobal.com
Email: [email protected]
Phone: 0800 2 MEDTECH (633 832)